Citadel Advisors’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-20,530
Closed -$169K 10186
2018
Q3
$169K Buy
+20,530
New +$154K ﹤0.01% 8332
2015
Q2
Sell
-5,308
Closed -$108K 9298
2015
Q1
$108K Buy
5,308
+733
+16% +$8.78K ﹤0.01% 6782
2014
Q4
$50K Sell
4,575
-2,133
-32% -$37.6K ﹤0.01% 7199
2014
Q3
$158K Buy
6,708
+4,382
+188% +$101K ﹤0.01% 5981
2014
Q2
$64K Sell
2,326
-13,585
-85% -$350K ﹤0.01% 6575
2014
Q1
$455K Buy
15,911
+995
+7% +$30.6K ﹤0.01% 4474
2013
Q4
$413K Sell
14,916
-63,617
-81% -$2.56M ﹤0.01% 4239
2013
Q3
$3.5M Buy
78,533
+74,350
+1,777% +$2.45M 0.01% 1883
2013
Q2
$87K Buy
+4,183
New +$55.4K ﹤0.01% 5318

Other funds holding HQCL

Citadel Advisors's HQCL Position: Q4 2018 in Review

Citadel Advisors sold out of Hanwha Q CELLS Co., Ltd. (HQCL) in Q4 2018, closing a stake of 20,530 shares — an estimated $169K sold.

Citadel Advisors first reported a position in HQCL in Q2 2013 and held it in 9 quarters. The position peaked at $3.5M in Q3 2013. 18 funds tracked by Wall St. Rank hold HQCL as of Q4 2018.

  • Citadel Advisors reported no remaining Hanwha Q CELLS Co., Ltd. position as of Q4 2018 after selling out during the quarter.
  • Citadel Advisors sold 20,530 Hanwha Q CELLS Co., Ltd. shares in Q4 2018, an estimated $169K.
  • Citadel Advisors first reported a position in Hanwha Q CELLS Co., Ltd. in Q2 2013 and held it in 9 quarters.
  • Citadel Advisors's Hanwha Q CELLS Co., Ltd. position peaked at $3.5M in Q3 2013.
  • 18 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q4 2018.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.